Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
DURHAM, N.C., March 29, 2016 -- In the release issued earlier today by Argos Therapeutics (Nasdaq:ARGS), please note that the "Selected Third Quarter 2015 Financial Results" header should be "Selected Fourth Quarter and Full-Year 2015 Financial Results." All other information in the press release remains the same.
Media contacts: Adam Daley Berry & Company Public Relations 212-253-8881 [email protected] Investor contact: John Menditto Argos Therapeutics, Inc. 919-908-0687 [email protected]
